“(Dr. Ian) Mitchell, who is participating in a randomized controlled study on the effects of cannabis on patients with post-traumatic stress syndrome, said a lot of what is known about the harms of marijuana also comes from observational data.
He also noted randomized controlled studies examining the benefits of marijuana have been suppressed for decades due to a research blockade in the U.S.”
Read more: Kamloops This Week
The Medicinal Cannabis Resource Centre Inc. is now open in Halifax, Nova Scotia!
MCRCI is now coast to coast across Canada after having opened our doors in Halifax.
We are excited to have the opportunity to assist patients on the East Coast offering our education and guidance in medicinal cannabis and Health Canada’s Access to Medicinal Purposes Regulations (ACMPR) program.
MCRCI began our commitment to helping patients in 2010 opening our first location in Vancouver, British Columbia.
Since then we have been able to open our doors into 2 more BC cities, Vernon and Kamloops allowing us to help patients in the Okanagan Valley and surrounding areas.
Our move to Halifax has been something that we have been working toward since our initial opening in 2010. We are very proud to now have our feet on the ground on the East Coast! After spending time in Nova Scotia, our team has met wonderful individuals who we believe are a great representation of the patients we will be meeting moving forward.
We encourage anyone who is interested in learning more about cannabis as a medicine to contact us at our new Halifax location:
128 – 1535 Dresden Row
Phone: 902 405 5553
Email: [email protected]
Fax: 902 417 1413
Information released July 2018
For the full PDF version, please follow this link: Complete Provincial Breakdown for Cannabis Regulations – July 2018
As recreational cannabis legalization draws closer, some companies are missing the mark when it comes to employer training.
Last Friday, the Greater Vancouver Board of Trade hosted ‘Cannabis in the Workplace’—a discussion to address employer concerns regarding the changes to federal and provincial laws.
With a two-hour time limit, the event set out to answer the not-so-simple question: “What do employers need to be considering and how do they need to be preparing now for legal cannabis and the workplace?”
It’s important to note that while medical cannabis has been legal for nearly two decades, the number of Canadians now registered in the federal program has shot up to over 230,000, leaving employers scrambling to update their policies and educate supervisors.
Barring a few pot quips and iterations of uncertainty, the conference fell dramatically short of providing much clarity. What could have been an opportunity to outline cannabis-specific policy changes and accommodations for employees with medical prescriptions, dissolved quickly into a vague Q & A period urging employers to turn their focus toward risk mitigation and potential lawsuits.
To clarify the details, keynote speaker Solicitor General Mike Farnworth opened the luncheon with a bullet point overview of the new regulatory framework, in which he made it very clear that there will be zero tolerance for impairment in the workplace. “Employees have a duty to come to work sober and nothing about cannabis legalization will change that,” he said. The term ‘impairment’ stuck and dictated the conversation throughout the remaining panel discussion.
Right out of the gate, Dave Earle, CEO of the B.C. Trucking Association, reaffirmed employer attention needs to stay on the issue of cannabis abuse in the workplace. “For employers that don’t believe you have a substance use issue in your workplace, I’m going to break it to you…you do,” he said.
While impairment is absolutely a pressing concern, especially in safety sensitive work environments, most of the policies the panel went on to address already exist to tackle substances like alcohol or prescription medication, even cannabis.
Taking on the human rights angle, Cindy Zheng, a lawyer with McQuarrie Hunter LLP, warned employers of potential violations where underlying medical conditions exist. It seemed the conversation was about to take the right turn, but after continuously linking cannabis with cocaine and alcohol, however, she failed to specifically address what it means to accommodate up to the point of undue hardship—the threshold set by the B.C. Human Rights Legislation.
Zheng went on to suggest employers fall back on existing alcohol and tobacco policies, until, that is, they run into discrepancies.
“We would recommend an outright prohibition on site,” she says. Later adding, “if there is a distinction, and I’m not saying there should be, but if there is, make sure you have an articulate and reasonable basis for that distinct treatment of cannabis.”
Excluding the fundamental distinction that should be made from a medical standpoint, the number of reasons to encourage employers to understand the difference between alcohol and cannabis are seemingly endless. Let’s start with addiction rates, behavioural tendencies and overall health implications, and see if we can find a “reasonable basis” somewhere in there.
Mike Kilgallin, a partner at Rober Greyell LLP, urged employers use their own judgement when it comes to swift action, or at least until science provides a more suitable alternative.
“While we may not be able to definitively prove somebody is impaired, we want to say “there is a risk” and we want to remove [that individual] from the workplace,” says Kilgallin.
“There are going to be a lot of level-headed employees who are going to understand [expectations] and who are going to not turn the lunch room into a hotbox,” Kilgallin added. “Focus on the small few, the ones who create problems.”
It wasn’t made clear if the trouble-makers he was referring to included medical cannabis patients or just potheads who now felt empowered by the new legislation to get stoned mid-shift. One would assume the latter, but since there was hardly any reference throughout the entire conversation to dealing with medical users, it was hard to tell.
One quick-fix posed by the panelists was the integration of a self-disclosure policy. Employees would be encouraged to go on record with their addiction and dependency issues in order to protect themselves and the company. The idea here is that if the issue is not disclosed pre-incident, they would not be entitled to safeguards like rehabilitation and graduated reintegration programs.
CEO of the Medical Cannabis Resource Centre Inc., Terry Roycroft, suggests this policy, made infamous by a lawsuit won by Elk Valley Coal in Alberta last year, won’t do much when it comes to cannabis. “That would be a very difficult thing to ask,” says Roycroft. “Most people aren’t going to consider even high recreational use an addiction.”
Roycroft, who is now in the process of helping several patients apply for cannabis coverage under their workplace medical insurance, says that companies have several options to work with their employees.
“There are products that can be prescribed by a doctor that will not get them impaired,” says Roycroft. Going one step further, one of the areas MCRCI specializes in is creating specific healthcare programs for individuals based on their condition and day-to-day demands. “We can work with their HR departments […] and make recommendations of when they could use psychoactive THC and when they would be safe to go back to work or safe to drive after that usage.”
Unfortunately, it seems some companies still have a long way to go before understanding the dire need to work with their employees in this new cannabis-friendly country. “Medical marijuana is just another substance,” said Earle. “You have to treat it like any other substance.” If that’s the level from which employers are to start their education, it will be a long and treacherous journey to a new workplace culture.
by Piper Courtenay on March 10th, 2018 at 10:00 AM
TORONTO — Sun Life Financial Inc. is adding medical marijuana coverage as an option for its group benefits plans, signalling an insurance industry shift and growing acceptance of the drug that bodes well for Canada’s burgeoning cannabis sector.
The Toronto-based insurer’s president and chief executive Dean Connor said the move was influenced by rising interest from Sun Life’s employer clients.
“Medical marijuana has become a very important part of their treatment program and pain management program,” said Connor, referring to patients who have cancer, multiple sclerosis, rheumatoid arthritis, or those requiring palliative care.
Currently, the vast majority of registered patients must pay for medical marijuana out of their own pockets. But the move by Sun Life, which provides health benefits coverage to more than three million Canadians and their families, or one-in-six Canadians, could set a precedent for other insurers.
The new offering comes as the country moves to legalize cannabis for recreational use later this year and as the number of registered medical marijuana patients grows. There were more than 235,000 medical marijuana patients in the system across Canada at the end of September 2017 — the most recent date for which data is available — more than double the roughly 98,500 a year earlier, noted Vahan Ajamian, a Beacon Securities Ltd. research analyst.
“The insurance companies have been getting pressure to cover this as a regular medicine,” he said.
Meanwhile, pharmacists and pharmacies have also been warming up to cannabis.
Shoppers Drug Mart has lined up supply agreements with licensed producers, conditional upon Health Canada’s approval of its application to dispense the drug. The Canadian Pharmacists Association and two Quebec groups representing the industry have also said that pharmacies should play a leading role in medical marijuana’s distribution.
Jonathan Zaid, the executive director of patient advocacy group Canadians for Fair Access to Medical Marijuana, said Sun Life’s enhanced coverage comes after years of litigation to gain acceptance for medical marijuana.
“Although there may not be immediate benefit for patients as specific plan sponsors will need to purchase the coverage, this move will make covering medical cannabis simpler than today’s exception process and speaks volumes to the broader acceptance and legitimacy of medical cannabis,” he said.
A number of plan sponsors have moved to cover medical cannabis costs over the years, Zaid noted, including the University of Waterloo’s student union, the Arthritis Society, Loblaw Companies Ltd., the Ontario Public Service Employees Union (OPSEU), and the Labourers’ International Union of North America. Those plans have varying eligibility criteria and levels of coverage, he added.
Starting March 1, plan sponsors with Sun Life will have the option to add medical cannabis coverage to extended health-care plans, ranging from $1,500 to $6,000 per covered person per year.
Medical cannabis coverage will be available for specific conditions and symptoms associated with cancer, rheumatoid arthritis, multiple sclerosis, HIV-AIDS, and palliative care.
In order to qualify for coverage, Sun Life plan members must meet specific criteria including an authorization letter from a physician and registration with a medical marijuana producer licensed with Health Canada.
Sun Life will also conduct periodic reviews of the growing body of clinical research supporting the use of medical cannabis for other conditions, and update its criteria if necessary, the company said in a document updating their client base of 22,300 plan sponsors.
Although this coverage does not encompass the full range of conditions and it is unclear how many businesses will use it, the insurer’s new offering is a positive development for Canada’s licensed medical marijuana producers, said Ajamian.
“Anything that makes it easier/cheaper for patients to get access should result in more patients, more volume, and (especially if it’s free) potentially more pricing power for producers,” he said in an email.
Manulife Financial Corp., one of Canada’s biggest insurers, offers medical cannabis coverage to clients on a selective basis, a spokesperson said.
“Manulife is supportive of clients that want to consider introducing medical cannabis as an option,” the spokesperson said in an emailed statement. “We also recommend that clients put limits and some management controls in place as this is an emerging market that is quickly evolving.”
As acceptance among insurers and employers appears to grow, a landmark battle over coverage of medical marijuana that helped add to the public conversation remains in the hands of the Nova Scotia Court of Appeal.
In October 2016, ThyssenKrupp Elevator Canada elevator mechanic Gordon Skinner went before the province’s Human Rights Tribunal over his union’s denial of coverage for his prescribed medical marijuana. The Nova Scotia man was injured in a motor vehicle accident in August 2010 while working, and was later prescribed medical cannabis to help with chronic pain. In January 2017, the tribunal ruled that the Board of Trustees of the Canadian Elevator Industry Welfare Trust Fund discriminated against Skinner, and ruled that his employer must cover medical marijuana.
The union took the case to the Nova Scotia Court of Appeal last fall, and Skinner is now awaiting the final ruling, said his counsel Hugh Scher.
Scher is optimistic about the outcome and noted Sun Life’s new offering is “a very positive development in the sense of recognizing the efficacy of medical marijuana, and attempting to provide for a means of enabling employers and insurers to address that need.”
Companies in this story: (TSX:SLF, TSX:MFC)
Armina Ligaya, The Canadian Press, Feb. 15, 2018.
By Staff The Canadian Press
MONTREAL – Prime Minister Justin Trudeau says “next summer,” and not July 1, is the date cannabis will become legal across the country.
Excerpts of an interview Trudeau gave the TVA network in Quebec were broadcast Tuesday, with the full interview to be shown Wednesday night.
READ MORE: Canadians could pay at least $1 per gram in weed tax, plus GST: feds
Trudeau shook his head when interviewer Pierre Bruneau asked him why he was so obsessed with July 1 as the date for the cannabis legislation to become law.
The prime minister said it “would not be July 1,” but that it would be “for next summer.”
“The date will not be July 1, I can assure you of that,” Trudeau said. “I don’t know where that date came from.”
Several provinces have asked the federal government to delay passing the legislation in order to give them more time to prepare.
A statement issued by the Health Department last month said, “as previously indicated, the government of Canada intends to bring the proposed Cannabis Act into force no later than July 2018.”
The Liquor Control Board of Ontario (LCBO) has created a website to keep the public updated on their process of preparing for the sale of legal cannabis by July 2018.
The website, lcbocannabisupdates.com, provides introductory information to the general public to help understand the steps the LCBO is taking to find the 40 initial cannabis store locations that the province has said they intend to have in place for legalization. The province intends to have 80 stores by 2019 and ‘up to’ 150 stores by 2020.
Although still short on specifics, the website contains a FAQ section that says the government plans to train all employees selling cannabis in the LCBO to know about the products and related safety information relating to them.
It also states that the Government of Ontario will be choosing locations for their first 40 stores with the goal of reducing the amount of illegal stores, “including dispensaries,” that are currently operating in Ontario.
Municipalities identified for a location will have an opportunity to have input in the process.
The age limit for consumption and possession in the province will be 19 and all cannabis sales will be through employees, not direct-to-customers sales, via traditional vending machines, for example.
Sourced from: Lift News – https://news.lift.co/lcbo-unveils-retail-cannabis-website/
The budding marijuana industry is spurring new research around cannabis that will have long-term effects on a variety of fields, from farming to new medicine, as companies look for solid scientific data on the substance.
With the looming legalization of recreational pot next summer, and the expansion of licensed medical marijuana producers, scientists at the University of Guelph say more organizations are turning to researchers for help growing better plants.
The Ontario university has a long horticultural research history and some of its staff and students are already deep into the study of medicinal marijuana.
20,000 ideas and counting: B.C. offers feedback on legal cannabis
Toronto cannabis lounges to ask for the right to exist legally
Ontario unveils pot plan, including online ordering, 150 stand-alone stores
On Friday, a team of two environmental science professors and a graduate student published a research paper — one they called the first of its kind and the first of many to come — about optimizing the growth of medicinal cannabis indoors.
The study looked at the rate of organic fertilizer in soilless products holding cannabis before it flowered and the optimization of tetrahydrocannabinol — the primary psychoactive part of cannabis — and cannabidiol, which has been touted as a potential treatment for certain forms of epilepsy.
“There is hardly any scientific information on how to produce these plants and now there is so much interest in this area,” said Youbin Zheng, who led the study funded by a licensed medical marijuana producer as well the federal government.
Words such as “OG kush” and “grizzly” — types of marijuana strains — have now appeared in a scientific journal, this time in HortScience, and there’s more to come.
Zheng and fellow professor Mike Dixon have a series of studies in the pipeline that examine the effects of irrigation, lighting, fertilization and soilless technology on cannabis growth as they try to bring scientific rigour to marijuana research.
Building on anecdotal evidence
Dixon is blunt when reflecting on the current cannabis research landscape.
“Much of the work now is largely based on anecdotal bulls–t from people who think they have it all figured out and did all their research in their basements,” he said.
The idea now, he notes, is to take the medicinal marijuana world from the backwoods to pharmaceutical-grade production.
Liberals’ pot bill tweaked to add timeline for edibles
Cannabis black market will thrive without an inclusive legal industry, MPs hear
Dixon has been part of pioneering research into the growth of plants in space and is using that knowledge and technology to help grow better medicinal marijuana. He plans to leverage the windfall of research money coming in from cannabis companies for his work.
“I’m shamelessly taking advantage of the cannabis industry sector’s investment,” he said.
“The bottom line is we’re developing technologies that will allow Canadians to exploit production systems in harsh environments.”
Marijuana production companies — there are more than 60 approved by Health Canada now — need a “huge number of trained scientists,” Zheng noted.
Then there are the potential medical applications associated with marijuana — there are more than 150 compounds found in cannabis that need to be explored, Dixon said.
Another big area is vertical farming — where crops are grown in stacks in vast warehouses with artificial lighting, either in solution or with soilless products — that can allow cold-climate countries to grow food year round, Dixon said.
The results of research on marijuana — driven by interest from the cannabis industry — could be applied to other areas, he explained.
“The funding isn’t coming from food, which has the lowest possible margin as a commodity, but pharmaceuticals,” Dixon said.
“But we can use this research to develop life-support technology, as in food, which can become an economic engine for a country like Canada that will carry us for the next 300 years.”
The dean of the Ontario Agricultural College, at the University of Guelph said the cannabis industry is also expected to help draw new students to the school’s programs.
“One of our greatest challenges is recruiting people into our programs because people typically don’t understand the fact that agriculture and food are high-tech, high-growth sectors and demand an awful lot of people for really interesting careers,” said Rene Van Acker.
“The cannabis industry is doing us a favour by drawing a lot of attention to the sector and drawing attention to the fact it is a high-skill, high-tech area.”
© The Canadian Press, 2017
The Canadian Press
Onerous regulations appear to be negatively impacting the cannabis business growth in Canada.
Specifically, current organizational structures may be too strict to allow production to meet demand for cannabis oils and extracts. While the number of applications for cannabis licensing continues to climb, many entrepreneurs are skipping the step of extraction, presumably in a move to limit potential liabilities by keeping initial operations to the basics of production and distribution.
Tyler Nvquvest of Business Vancouver cited a recent Health Canada report which shows a growth in the cannabis oil sector of more than 871% between April 2016 and March 2017, and pointed out the overall lack of cannabis oil production licenses – only 18 of the 51 licenses granted by Canadian authorities include a plan to produce and sell oil:
“The regulatory system is not structured to solely license companies exclusively focused on oil extraction, said Rosy Mondin, executive director at the Cannabis Trade Alliance of Canada. Oil extraction carries extra restrictions and regulations governing dosage and application.
“‘The way the system is set up is that it is a complete seed-to-sale license,’ said Mondin. ‘If you want to process oils, you are forced to cultivate [marijuana].’
“…’When you look at consumption trends in the U.S. and use [them] as predicators to Canada, the prediction is that consumption of extracted oil and oil-based products is going to increase 198,000% over the next five years,’ Mondin said.”
While Canada is currently losing out on the cannabis oil market due to regulatory hurdles, that will likely change in the near future. Over regulation and supply chain bottlenecks have temporarily plagued other marijuana markets, but the cannabis community is creative and persistent and elected officials like tax dollars. We can expect advocates and politicians to work out some common sense solutions, especially as legalization becomes more mainstream in Canada.
Keep up with the latest in Canada’s cannabis business development! Join the International Cannabis Business Conference in Kauai, Hawaii on December 1-3, 2017, and Vancouver, British Columbia in June 24 and 25, 2018.
Author: AMBER IRIS LANGSTON- Date: OCTOBER 3, 2017
MariCann expansion establishes Norfolk as primary site today, in future
Photo by Jeff Tribe
MariCann Inc. looks forward to ‘growing green with green’ in its state-of-the-art $8-million 180,000-square-foot expansion.
“This is the field of dreams,” said VP of Operations Richard Kropman, indicating a large, fenced rectangle dotted with heavy machinery.
On a drizzly January morning, the target area on the MariCann property southeast of Glen Meyer was a muddy expanse. But for what Director of Media and Investor Relations Shawn Alexander describes as a startup company in a startup industry, ambitious dreams are well on their way to reality.
“We refer to it as scaling up,” understated Alexander of a 700-per-cent expansion from the current 30,000 square-foot self-contained indoor grow, production and distribution facility.
“In eight months, you’re going to see roughly 180,000 square feet of buildings standing where that second dirt pile is,” added Kropman, pointing.
MariCann Inc. is a licenced producer under Health Canada Access to Cannabis for Medical Purposes Regulations (ACMPR), one of 23 in Ontario and 38 nationwide. Created in 2013 by a founder who believes in the therapeutic practicality and effectiveness of cannabis, the company says its expertise includes a track record of creating shareholder wealth combined with experience in the pharmaceutical sector. Although currently a private company, plans are for its listing as a public entity on the Toronto Stock Exchange.
The emergence of cannabis from black market to highly-regulated and quality-assured white market medical product with multi-billion-dollar potential is driving what MariCann CEO Ben Ward (who holds an MBA with a dual concentration in operations and finance from Bradford University School of Management in England) calls only the ‘first big new phase’ on the 97.5-acre property. There are 90 acres of buildable space in total says Ward, cradling the long-term goal of creating the largest operation in the world.
“Right in Norfolk County. Norfolk County offers all the opportunity and infrastructure to allow us to do that.”
MariCann’s roots were planted via a September, 2013 handshake deal with the former owner of a MMAR (earlier Medical Marijuana Access Regulations for smaller ‘cottage industry’ operations where patients grew their own cannabis or had it grown for them) site.
The existing MMAR facility assisted in the transition to contemporary ACMPR licensing on a property with ample access to water, electrical grid and natural gas. Combined with required facilities, Health Canada regulations create a significant financial barrier to entry into the medical marijuana business, Kropman indicating a generally accepted ballpark of $9-million, and MariCann’s own $8-million startup total.
“It’s not throwing seeds in the ground and watching money come in, it’s not easy,” says VP Information Technology and Security Stephen Lem, who has 30 years of experience including working with Fortune 500 companies DuPont, Amgen and Actavis. “It requires a lot of discipline and a lot of planning.”
MariCann began operations with roughly a dozen employees, received its licence to sell in December, 2014 and sold its first product on the 20th of that month. The operation currently employs 60 in a self-contained production, processing and distribution facility which doubled sales in its second year. Expansion was always part of long-term planning and the current phase began November 22, 2016.
“We’re moving to 205,000 square feet in total,” said general contractor Jeff Ayotte, noting the new facility will have a 30,000 square-foot nursery, equal in size to the current total. First production is scheduled for the end of March, 2018.
Employment is anticipated to rise from current levels to between 80 and 100 upon project completion says Kropman. Due to its higher-tech automated nature, a majority of the new hires will be in quality control and supervisory roles.
“It will be more operations.”
It was Ayotte who mentioned the phrase ‘growing green with green’ for a project which includes lowering carbon footprint as a design element. The possibility of installing solar panels on the production facility’s roof has been investigated says Ayotte, along with various options for the site’s operational natural gas well, including gas-fired co-gen electricity production under island (off the grid) or parallel (selling back to the grid) models.
“Energy conservation on this project is huge.”
MariCann’s No. 1 priority is producing top-quality cannabis under practices which not only meet, but exceed the high bar of standards set by Health Canada. But environmentally-responsible operations also lower significant input costs for its controlled-environment (greenhouse) agriculture base, display a leading-edge approach for Health Canada, and offer ‘green’ branding advantages for clients.
“It’s a comfort level with our customers as well,” said Ayotte.
The first expansion project’s size is only part of a story that includes evolving technology in creating consistent production of a consumable food-grade item destined for pharmacy-level processing inside a controlled but fluctuating growing environment. Ayotte touched on some of the more technical aspects of a facility that to sum up succinctly, will not rely as heavily on equipment or practices converted from other uses, but more so feature dedicated state-of-the-art cannabis-producing technology.
“It kind of puts Norfolk County on the map and sets standards for production facilities.”
The process has been assisted says Ayotte, not only by the county’s support, but its natural and human advantages.
“We have a large talent pool to draw from and support us in this expansion.”
The site is currently MariCann’s lone production facility and will remain the company’s key production facility moving forward, says Kropman.
“This is an exciting phase of the industry,” he concluded. “MariCann is looking forward to expanding in Norfolk County and being part of a long-term win-win situation.”